keyword
https://read.qxmd.com/read/38535094/mitral-valve-surgery-for-mitral-regurgitation-results-in-reduced-left-ventricular-ejection-fraction-in-barlow-s-disease-as-compared-with-fibro-elastic-deficiency
#1
JOURNAL ARTICLE
Lobke L Pype, Philippe B Bertrand, Philippe Debonnaire, Sebastiaan Dhont, Boukje Hoekman, Bernard P Paelinck, Dina De Bock, Hein Heidbuchel, Emeline M Van Craenenbroeck, Caroline M Van De Heyning
Surgical correction of severe mitral regurgitation (MR) can reverse left ventricular (LV) remodeling in patients with mitral valve prolapse (MVP). However, whether this process is similar to the case in Barlow's Disease (BD) and Fibro-elastic Deficiency (FED) is currently unknown. The aim of this study is to evaluate post-operative LV reverse remodeling and function in patients with BD versus FED. In this study, 100 MVP patients (BD = 37 and FED = 63) with severe MR who underwent mitral valve surgery at three Belgian centers were retrospectively included...
February 21, 2024: Journal of Cardiovascular Development and Disease
https://read.qxmd.com/read/38531070/prognostic-value-of-left-ventricular-global-longitudinal-strain-in-transcatheter-edge-to-edge-repair-for-chronic-primary-mitral-regurgitation
#2
JOURNAL ARTICLE
Alon Shechter, Gloria J Hong, Danon Kaewkes, Vivek Patel, Parth Visrodia, P Ryan Tacon, Ofir Koren, Keita Koseki, Takashi Nagasaka, Sabah Skaf, Moody Makar, Tarun Chakravarty, Raj R Makkar, Robert J Siegel
AIMS: Left ventricular global longitudinal strain (LVGLS) is a known outcome predictor in transcatheter edge-to-edge repair (TEER) for functional mitral regurgitation (MR). We aimed to assess its prognostic yield in the setting of TEER for chronic primary MR. METHODS AND RESULTS: We conducted a single-center, retrospective analysis of 323 consecutive patients undergoing isolated, first-time procedures. Stratified by baseline LVGLS quartiles (≤-19%, -18.9-(-16)%, -15...
March 26, 2024: European Heart Journal Cardiovascular Imaging
https://read.qxmd.com/read/38530687/the-natural-history-of-atrial-functional-mitral-regurgitation
#3
JOURNAL ARTICLE
Jwan A Naser, Francisco B Alexandrino, Tomonari Harada, Hector I Michelena, Barry A Borlaug, Mackram F Eleid, Grace Lin, Christopher Scott, Austin M Kennedy, Patricia A Pellikka, Vuyisile T Nkomo, Sorin V Pislaru
BACKGROUND: The natural history of moderate/severe atrial functional mitral regurgitation (AFMR) is unknown. OBJECTIVES: The authors sought to study the incidence of left ventricular (LV) systolic dysfunction (LVSD), progression or regression of ≥mild-moderate AFMR, and impact on mortality. METHODS: Adults with left atrial (LA) volume index ≥40 mL/m2 , ≥mild-moderate AFMR, and follow-up echocardiogram were followed for incident LVSD (ejection fraction <50% and ≥10% lower than baseline), progression of mild-moderate/moderate AFMR to severe, and persistent regression of AFMR to no/trivial...
March 17, 2024: Journal of the American College of Cardiology
https://read.qxmd.com/read/38529422/advancements-in-mitraclip-intervention-for-mitral-regurgitation-a-comprehensive-review-and-comparative-analysis-of-clinical-trials
#4
REVIEW
Shitij Shrivastava, Shashwat Shrivastava, Sai Vishnu Vardhan Allu, Patrik Schmidt, Moiud Mohyeldin, Abeer Qasim
This comprehensive review explores the evolution and clinical impact of MitraClip intervention in the management of mitral regurgitation. Mitral regurgitation results from dysfunction in the mitral valve (MV) apparatus. The MitraClip Clip Delivery System was approved by the Food and Drug Administration (FDA) in 2013. The discussion delves into the procedural foundation of MitraClip intervention, primarily based on Alfieri's technique of edge-to-edge leaflet approximation. As highlighted by key clinical trials, including Endovascular Valve Edge-to-Edge Repair (EVEREST) II Trial, Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation (COAPT) Trial, and Percutaneous Repair with the MitraClip Device for Severe Functional/Secondary Mitral Regurgitation (MITRA-FR) trial, the efficacy and safety of MitraClip were evaluated in comparison to surgical interventions and guideline-directed medical therapy...
February 2024: Curēus
https://read.qxmd.com/read/38524030/graded-mobilization-with-pacing-technique-for-functional-mobility-in-a-preoperative-marfan-syndrome-case-of-aortic-root-dilation-a-case-report
#5
Sawari S Bhagwatkar, Vaishnavi Yadav, Prajyot Ankar, Neha Arya
Marfan syndrome (MFS) presents complex cardiovascular manifestations and challenges in management due to its impact on multiple body systems. This case study examines the clinical profile, diagnostic findings, and physiotherapy intervention for a 57-year-old male with MFS who experienced severe aortic and mitral valvular complications. The patient's admission was marked by fatigue, reduced mobility, breathlessness, and a confirmed diagnosis of MFS. Cardiac evaluation revealed severe regurgitation and aortic root dilation...
February 2024: Curēus
https://read.qxmd.com/read/38523390/camptodactyly-arthropathy-coxa-vara-pericarditis-syndrome-and-an-unusual-association-with-mitral-stenosis
#6
Duygu Şimşekli, Canan Ayabakan, Ayla Oktay, Ahmet Arnaz, Vusal Mahmudov, Yusuf Kenan Yalçınbaş
BACKGROUND: Campotodactyly-artrhropathy-coxa vara-pericarditis (CACP) syndrome is a very rare autosomal recessive genetic disorder. It is characterized by flexion contracture of the fifth finger (camptodactyly); noninflammatory arthropathy; decreased angle between the shaft and the head of the femur (coxa vara) and pericarditis. Its association with mitral stenosis has not yet been reported. Hereby we report this unique association with CACP syndrome. CASE: An eleven-year-old girl presented with non-productive cough, dyspnea, and orthopnea...
2024: Turkish Journal of Pediatrics
https://read.qxmd.com/read/38522637/functional-mitral-regurgitation-and-heart-failure-with-preserved-ejection-fraction-clinical-implications-and-management
#7
REVIEW
M Riccardi, M Cikes, M Adamo, M Pagnesi, C M Lombardi, S D Solomon, M Metra, R M Inciardi
Heart failure with preserved ejection fraction (HFpEF) is highly prevalent and associated with worse cardiovascular outcomes. The pathophysiology of HFpEF mostly relies on the development of elevated left ventricle filling pressure, diastolic dysfunction, atrial dilatation and impairment. This dynamic process may eventually lead to the development of functional mitral regurgitation, characterized by mitral annular dilatation and consequent leaflet remodelling, in the context of preserved left ventricular ejection fraction...
March 22, 2024: Journal of Cardiac Failure
https://read.qxmd.com/read/38520314/echocardiographic-haemodynamic-monitoring-in-the-context-of-heartmate-3%C3%A2-therapy-a-systematic-review
#8
JOURNAL ARTICLE
Linus Ohlsson, Joanna-Maria Papageorgiou, Tino Ebbers, Meriam Åström Aneq, Éva Tamás, Hans Granfeldt
AIMS: While echocardiography remains essential within haemodynamic monitoring of durable mechanical circulatory support, previous echocardiographic guidelines are missing scientific evidence for the novel HeartMate 3™ (HM3) system. Accordingly, this review aims to summarize available echocardiographic evidence including HM3. METHODS AND RESULTS: This systematic review adhered to the PRISMA 2020 guidelines. Searches were conducted during August 2023 across PubMed, Embase, and Google Scholar using specific echocardiographic terms combined with system identifiers...
March 23, 2024: ESC Heart Failure
https://read.qxmd.com/read/38515335/long-term-cost-effectiveness-of-transcatheter-mitral-valve-repair-in-%C3%A2-hf-patients-with-secondary-mitral-regurgitation
#9
JOURNAL ARTICLE
Younan Yao, Ziyou Zhou, Tian Geng, Anping Cai, Tian Li, Junqing Yang, Jiyan Chen, Liwen Li
AIMS: The long-term cost-effectiveness of MitraClip in heart failure patients with secondary mitral regurgitation is still unclear. This study aimed to evaluate the long-term cost-effectiveness of MitraClip added to guideline-directed medical therapy vs. guideline-directed medical therapy alone in heart failure patients with secondary mitral regurgitation from the perspective of the healthcare systems of mainland China, the United Kingdom, Germany, and the United States. METHODS AND RESULTS: A two-stage (decision + Markov) model was built...
March 22, 2024: ESC Heart Failure
https://read.qxmd.com/read/38509384/sequential-composite-bima-grafting-for-3v-cad-factors-that-predict-successful-outcome-of-the-one-inflow-and-two-inflow-revascularization-techniques
#10
JOURNAL ARTICLE
Terézia B Andrási, Alannah C Glück, Ildar Talipov, Lachezar Volevski, Ion Vasiloi
OBJECTIVE: The effect of one-inflow and two-inflow coronary surgical revascularization techniques inclosing skeletonized double mammary artery (BIMA) as T-graft on outcome is studied. METHODS: Early ad mid-term outcome of complete BIMA revascularization (C-T-BIMA) versus left-sided BIMA with right-sided aorto-coronary bypass (L-T-BIMA + R-CABG) is quantified and analyzed by multivariate logistic regression, Cox-regression, and Kaplan-Meier analysis in a series of 204 consecutive patients treated for triple-vessel coronary disease (3v-CAD)...
March 20, 2024: General Thoracic and Cardiovascular Surgery
https://read.qxmd.com/read/38502857/efficacy-of-mitral-valve-repair-in-combination-with-coronary-revascularization-for-moderate-ischaemic-mitral-regurgitation-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials
#11
JOURNAL ARTICLE
Xin Li, Biao Hou, Shuwen Hou, Hongjia Zhang, Yuyong Liu, Wenjian Jiang
BACKGROUND: The efficacy of mitral valve repair (MVR) in combination with coronary artery bypass grafting (CABG) for moderate ischaemic mitral regurgitation (IMR) remains unclear. To evaluate whether MVR + CABG is superior to CABG alone, the authors conducted a systematic review and meta-analysis of existing randomized controlled trials (RCTs). METHODS: The authors searched PubMed, Web of Science, and the Cochrane Central Register of Controlled Trials for eligible RCTs from the date of their inception to October 2023...
March 19, 2024: International Journal of Surgery
https://read.qxmd.com/read/38497794/prevalence-and-clinical-outcomes-of-isolated-or-combined-moderate-to-severe-mitral-and-tricuspid-regurgitation-in-patients-with-cardiac-amyloidosis
#12
JOURNAL ARTICLE
Daniela Tomasoni, Alberto Aimo, Aldostefano Porcari, Giovanni Battista Bonfioli, Vincenzo Castiglione, Riccardo Saro, Mattia Di Pasquale, Maria Franzini, Iacopo Fabiani, Carlo Mario Lombardi, Laura Lupi, Marta Mazzotta, Matilde Nardi, Matteo Pagnesi, Giorgia Panichella, Maddalena Rossi, Giuseppe Vergaro, Marco Merlo, Gianfranco Sinagra, Michele Emdin, Marco Metra, Marianna Adamo
AIMS: Evidence on the epidemiology and prognostic significance of mitral regurgitation (MR) and tricuspid regurgitation (TR) in patients with cardiac amyloidosis (CA) is scarce. METHODS AND RESULTS: Overall, 538 patients with either transthyretin (ATTR, n = 359) or immunoglobulin light-chain (AL, n = 179) CA were included at three Italian referral centres. Patients were stratified according to isolated or combined moderate/severe MR and TR. Overall, 240 patients (44...
March 18, 2024: European Heart Journal Cardiovascular Imaging
https://read.qxmd.com/read/38493834/progression-of-mild-mitral-annulus-calcification-to-mitral-valve-dysfunction-and-impact-on-mortality
#13
JOURNAL ARTICLE
Muhannad Aboud Abbasi, Abdullah Al-Abcha, Alex T Lee, Christopher G Scott, Mayra Guerrero, Patricia A Pellikka
BACKGROUND: Mitral annulus calcification (MAC) represents a degenerative process resulting in calcium deposition in the mitral valve apparatus. MAC is associated with adverse clinical outcomes. We sought to examine the long-term significance of mild MAC and its relationship to subsequent mitral valve dysfunction (MVD) and mortality in patients without MVD on the initial echocardiogram. METHODS: A total of 1420 patients with mild MAC and no MVD at baseline, and one or more follow-up echocardiograms at least one year after the baseline echocardiogram were included in the analysis...
March 15, 2024: Journal of the American Society of Echocardiography
https://read.qxmd.com/read/38481714/eligibility-and-potential-benefit-of-transcatheter-edge-to-edge-repair-in-a-contemporary-cohort-with-heart-failure-evidence-from-a-large-integrated-health-care-delivery-system
#14
JOURNAL ARTICLE
Andrew P Ambrosy, Jingrong Yang, Andrew S Tai, Sadia J Dimbil, Elisha A Garcia, Sue Hee Sung, Ankeet S Bhatt, Matthew D Solomon, Ivy A Ku, Jacob M Mishell, Edward J McNulty, Jonathan G Zaroff, Andrew N Rassi, Jeremy Kong, Alan S Go
BACKGROUND: The eligibility and potential benefit of transcatheter edge-to-edge repair (TEER) in addition to guideline-directed medical therapy to treat moderate-severe or severe secondary mitral regurgitation (MR) has not been reported in a contemporary heart failure (HF) population. METHODS: Eligibility for TEER based on Food and Drug Administration (FDA) labeling: (1) HF symptoms, (2) moderate-severe or severe MR, (3) left ventricular ejection fraction (LVEF) 20% to 50%, (4) left ventricular end-systolic dimension 7...
March 2024: Structural heart: the journal of the Heart Team
https://read.qxmd.com/read/38481712/cardiac-structural-and-functional-remodeling-after-transcatheter-mitral-valve-in-valve-implantation-early-changes-and-prognostic-significance
#15
JOURNAL ARTICLE
Gloria Ayuba, Zhiying Meng, Abigail S Baldridge, Ansh Goyal, Blair Tilkens, Rishi Shrivastav, Taimur Safder, Chris S Malaisrie, James Flaherty, Patrick M McCarthy, James D Thomas, Charles Davidson, Jyothy Puthumana, Akhil Narang
BACKGROUND: Transcatheter mitral valve-in-valve (MViV) replacement has emerged as an alternative to redo mitral valve (MV) surgery for the management of failed bioprosthetic MVs. The degree of cardiac remodeling assessed by echocardiography has been shown to have prognostic implications in degenerative mitral regurgitation patients undergoing MV surgery. The impact of transcatheter MViV in patients with degenerative bioprosthetic MV failure on cardiac remodeling and its associated prognosis remains undescribed...
March 2024: Structural heart: the journal of the Heart Team
https://read.qxmd.com/read/38476375/simultaneous-management-of-aortic-and-mitral-regurgitation-through-one-stage-transcatheter-aortic-valve-replacement-and-transcatheter-edge-to-edge-repair-case-report
#16
Hao Lin, Mei Zhu, Meng Lv, Zhengjun Wang
This case report presents a 72-year-old male patient who presented with exertional dyspnea for over 10 years, which had progressively worsened over the past 4 months. Transthoracic echocardiography revealed severe aortic and mitral regurgitation, with a left ventricular ejection fraction of 37% and a left ventricular end-diastolic diameter of 64 mm. Despite receiving long-term optimal medical management, there was no improvement in symptoms or severity of valvular regurgitation. Given the relatively high surgical risk associated with double valve replacement in this elderly patient and his preference for minimally invasive procedures, a one-stage transapical aortic valve replacement and transcatheter mitral valve repair using the edge-to-edge technique were planned...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38471830/patient-risk-benefit-preferences-for-transcatheter-versus-surgical-mitral-valve-repair
#17
JOURNAL ARTICLE
Anna Hung, Jui-Chen Yang, Matthew Wallace, Brittany A Zwischenberger, Sreekanth Vemulapalli, Robert J Mentz, Elizabeth Thoma, Scott Goates, John Lewis, Susan Strong, Shelby D Reed
BACKGROUND: Transcatheter edge-to-edge repair (TEER) of mitral regurgitation is less invasive than surgery but has greater 5-year mortality and reintervention risks, and leads to smaller improvements in physical functioning. The study objective was to quantify patient preferences for risk-benefit trade-offs associated with TEER and surgery. METHODS AND RESULTS: A discrete choice experiment survey was administered to patients with mitral regurgitation. Attributes included procedure type; 30-day mortality risk; 5-year mortality risk and physical functioning for 5 years; number of hospitalizations in the next 5 years; and risk of additional surgery in the next 5 years...
March 12, 2024: Journal of the American Heart Association
https://read.qxmd.com/read/38469654/sex-differences-in-left-atrial-volumes-mechanics-and-stiffness-in-primary-mitral-regurgitation-a-combined-2d-and-3d-echocardiographic-study
#18
JOURNAL ARTICLE
Christian E Berg-Hansen, Rasmus Bach Sindre, Lisa Grymyr, Barbara Rogge, Andreas Valeur, Stig Urheim, Judy Hung, Dana Cramariuc
BACKGROUND: Mitral regurgitation (MR) causes left atrial (LA) enlargement and impaired reservoir function. We assessed whether changes in LA size, strain and stiffness in significant (moderate or greater) primary MR are sex-specific. METHODS AND RESULTS: In the 3D Echocardiography and Cardiovascular Prognosis in Mitral Regurgitation study (3D-PRIME), 111 patients with primary MR were prospectively investigated with 2D and 3D echocardiography. MR was severe if the 3D regurgitant fraction was ≥50%...
March 12, 2024: European Heart Journal Cardiovascular Imaging
https://read.qxmd.com/read/38465490/-supra-annular-mitral-valve-replacement-using-a-composite-valve-for-an-infant-with-acute-rupture-of-chordae-tendineae
#19
JOURNAL ARTICLE
Shinya Ugaki, Toshikazu Shimizu, Hisayuki Hongu, Kougi Nomura
Acute rupture of the chordae tendineae of the mitral valve could lead to severe mitral regurgitation and circulatory collapse in infants. Mitral valve replacement may be often challenging because of the valve-annulus size mismatch in small infants when mitral valve repair cannot be accomplished. We present an infant with acute massive rupture of the chordae tendineae of the mitral valve who successfully underwent supra-annular mitral valve replacement using the short composite valve of an expanded polytetrafluoroethylene( ePTFE) graft and a mechanical valve...
March 2024: Kyobu Geka. the Japanese Journal of Thoracic Surgery
https://read.qxmd.com/read/38464845/predicting-postoperative-systolic-dysfunction-in-mitral-regurgitation-ct-vs-echocardiography
#20
JOURNAL ARTICLE
Prajwal Reddy, Vidhu Anand, Prabhakar Rajiah, Nicholas B Larson, Jared Bird, James M Williams, Eric E Williamson, Rick A Nishimura, Juan A Crestanello, Arman Arghami, Jeremy D Collins, Alex Bratt
INTRODUCTION: Volume overload from mitral regurgitation can result in left ventricular systolic dysfunction. To prevent this, it is essential to operate before irreversible dysfunction occurs, but the optimal timing of intervention remains unclear. Current echocardiographic guidelines are based on 2D linear measurement thresholds only. We compared volumetric CT-based and 2D echocardiographic indices of LV size and function as predictors of post-operative systolic dysfunction following mitral repair...
2024: Frontiers in Cardiovascular Medicine
keyword
keyword
21638
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.